Scott Marek is assistant professor of radiology in the Mallinckrodt Institute of Radiology at Washington University School of Medicine in St. Louis. Marek received a Ph.D. in neuroscience from the University of Pittsburgh, where he gained expertise in pediatric neuroimaging with Beatriz Luna. Subsequently, he completed a postdoctoral fellowship with Nico Dosenbach at Washington University School of Medicine, where he gained expertise in functional mapping of individual brains and leveraging big data to quantify the reproducibility of brain-wide association studies. He now runs his own lab focused on precision imaging and deep phenotyping of adolescent twins with depression, as well as population neuroscience approaches using large datasets, such as the Adolescent Brain Cognitive Development (ABCD) Study.
Scott Marek
Assistant professor of radiology
Washington University School of Medicine in St. Louis
From this contributor
Breaking down the winner’s curse: Lessons from brain-wide association studies
We found an issue with a specific type of brain imaging study and tried to share it with the field. Then the backlash began.
Breaking down the winner’s curse: Lessons from brain-wide association studies
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.